期刊文献+

rhTPO对异基因造血干细胞移植模型造血重建的作用

Effect of Recombinant Human Thrombopoietin(rhTPO) on Hematopoietic Reconstitution in Allogeneic Hematopoietic Stem Cell Transplantation Model
下载PDF
导出
摘要 目的:探讨重组人血小板生成素(rh TPO)对异基因造血干细胞移植模型造血重建的作用。方法:以C57BL/6小鼠为供鼠,BALB/c小鼠为受鼠,分离供鼠骨髓单个核细胞,预处理后,给予受鼠尾静脉注射供鼠骨髓单个核细胞5×10^(6)/只,建立异基因造血干细胞移植模型,移植后d 28用流式细胞术检测受鼠骨髓造血干细胞植入情况。将建模成功后的受鼠随机分为两组,实验组于移植后d 1开始注射rh TPO,对照组注射生理盐水,两组均连续注射14 d。移植后d 1、3、7、14、21观察两组受鼠外周血及骨髓造血情况。结果:移植后28 d,受鼠骨髓H-2Kb表达率为43.85%(>20%),受鼠嵌合成功。移植后d 3、7、14、21,实验组受鼠血小板数高于对照组,比较差异具有统计学意义(P<0.05)。两组小鼠在移植后d 1、3、7均出现骨髓造血功能抑制,但实验组骨髓造血增生较对照组好。移植后d 14、21,两组小鼠骨髓造血功能均较前有所恢复,且实验组恢复明显。结论:rh TPO能有效刺激异基因造血干细胞移植后血小板生成,并促进移植后骨髓造血恢复及造血重建。 Objective:To explore the effect of recombinant human thrombopoietin (rh TPO) on hematopoietic reconstruction in allogeneic hematopoietic stem cell transplantation (allo-HSCT) model.Methods:The C57BL/6 mice were employed as the donors,and BALB/c mice as recipients.The bone marrow mononuclear cells of the donor mice were extracted and pretreated,which then were injected with 5×10^(6) per mouse through the tail vein of the recipient to establish an allo-HSCT model.The implantation of hematopoietic stem cells in the recipient mice was detected by flow cytometry on the 28th day after transplantation.Next,the successfully modeled recipient mice were randomly divided into experimental group and control group.The rh TPO was injected into mice in the experimental group on the first day after transplantation,while the saline was injected into mice in the control group.Both groups were injected for 14 consecutive days.The peripheral blood and bone marrow hematopoiesis of the two groups were observed on day 1,3,7,14,and 21after transplantation.Results:The expression rate of H-2Kb in the bone marrow of recipient mice was 43.85%(>20%) on the 28th day after transplantation,which indicated that the recipient mice were successfully chimerized.Meanwhile,counts of PLTs on the day 3,7,14,and 21 after transplantation in the experimental group were higher than those in the control group with statistical significances (P<0.05).In addition,hematopoietic function of bone marrow was suppressed in both groups on day 1,3 and 7 after transplantation,but hematopoietic bone marrow hyperplasia was better in the experimental group than in the control group.On day 14 and 21 after transplantation,the hematopoietic function of bone marrow in the two groups was recovered,and the experimental group showed more obvious than the control group.Conclusion:rh TPO can effectively stimulate the production of PLTs and facilitate the recovery of white blood cells and hemoglobin after allo-HSCT,and promote hematopoietic recovery and reconstitution of bone marrow.
作者 邱瑾 韩丽英 邢宏运 高坤丽 卞铁荣 QIU Jin;HAN Li-Ying;XING Hong-Yun;GAO Kun-Li;BIAN Tie-Rong(Department of General Medicine,Luzhou People's Hospital;Department of Hematology,The Affiliated Hospital of Southwest Medical University,Luzhou 646000,Sichuan Province,China;Department of General Medicine,The Affiliated Hospital of Southwest Medical University,Luzhou 646000,Sichuan Province,China;Medical Experiment Center,The Affiliated Hospital of Southwest Medical University,Luzhou 646000,Sichuan Province,China)
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2023年第1期241-246,共6页 Journal of Experimental Hematology
基金 泸州市科技局重点项目(2020-SYF-25)。
关键词 造血重建 异基因造血干细胞移植 重组人血小板生成素 小鼠 hematopoietic reconstitution allogeneic hematopoietic stem cell transplantation recombinant human thrombopoietin mice
  • 相关文献

参考文献2

二级参考文献13

  • 1Kaushansky K, Lok S, Holly RD, et al. Promotion of megakaryo- cyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature, 1994, 369: 565-571.
  • 2Kuter DJ, Begley CG. Recombinant human thrombopoietin:basic biology and evaluation of clinical studies. Blood, 2002, 100: 3457 -3469.
  • 3Mwamtemi HH, Higuchi T, Sawai N, et al. Quantitative and qualitative differences in thrombopoietin-dependent hematopoietic progenitor development between cord blood and bone marrow. Transplantation, 2000, 69 : 1645-1654.
  • 4Gothot A, van der Loo JC, Clapp DW, et al. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34 ( + ) cells in non-obese diabetic/severe combined im- mune-deficient mice. Blood, 1998,92 : 2641-2649.
  • 5Shilling HG, McQueen KL, Cheng NW, et al, Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood, 2003, 101 : 3730-3740.
  • 6Kuter DJ. New thrombopoietic growth factors. Blood, 2007,109 : 4607 -4616.
  • 7Kaushansky K. Thrombopoietin and the hematopoietic stem cell. Blood, 1998, 92 : 1-3.
  • 8Kaushansky K. Thrombopoietin. N Engl J Med, 1998, 339: 746- 754.
  • 9Webb I J, Anderson KC. Risks, costs, and alternatives to platelet transfusions. Leuk Lymphoma, 1999, 34: 71-84.
  • 10Tepler I, Elias L, Smith JW 2nd, et al. A randomized placebo- controlled trial of recombinant human interleukin-11 in cancer pa- tients with severe thrombocytopenia due to chemotherapy. Blood, 1996, 87: 3607-3614.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部